Issue - meetings
Herefordshire Pharmaceutical Needs Assessment 2025
Meeting: 15/09/2025 - Health and Wellbeing Board (Item 27)
27 Herefordshire Pharmaceutical Needs Assessment 2025
PDF 417 KB
This report seeks the approval of members for the publication of the 2025 Herefordshire Pharmaceutical Needs Assessment (PNA) on 1 October 2025 (the statutory deadline). The statutory 60-day consultation period for this PNA ended on 2 September 2025. Members are asked to note the consultation report (appendix 1) and to delegate final approval for publication to the PNA working group.
Additional documents:
- Appendix 1 - Consultation Report, item 27
PDF 675 KB
- Appendix 2 - Equality Impact Screening Checklist, item 27
PDF 401 KB
- Appendix 3 - Herefordshire PNA 2025 - Draft Main Document, item 27
PDF 5 MB
- Appendix 4 - Herefordshire PNA 2025 - Draft Main Document Appendices, item 27
PDF 261 KB
- Appendix 5 - Herefordshire PNA 2025 - Presentation to the Health and Wellbeing Board, item 27
PDF 793 KB
Minutes:
Ryan Davies presented the slides ‘Pharmaceutical Needs Assessment (PNA) 2025’, under the headings: Context and Process; Gap Analysis; Conclusions; and Recommendations.
The principal discussion points included:
1. All pharmacies were required to provide essential services, including: dispensing of prescriptions; dispensing of repeatable prescriptions; disposal of unwanted medicines; promotion of healthy lifestyles; signposting people who require advice, treatment or support to relevant providers; support for self-care; and discharge medicines service.
The Chairperson questioned the extent to which dispensing practices in rural areas provided services beyond basic dispensing. Some of the challenges for dispensing practices were noted, including building space constraints.
2. Zoe Clifford commended the work undertaken on the PNA, as it provided a comprehensive summary of the current state of play in Herefordshire.
3. There was a brief discussion about the potential role of pharmacies in the development of neighbourhood health services.
4. There was also a brief discussion about the challenges for patients and family members in ordering prescriptions. It was reported that the ongoing development of the NHS App was helping to streamline processes and provide access to records, albeit recognising the need to promote digital health services and address barriers to access and use.
Resolved: That
a) the Pharmaceutical Needs Assessment (PNA) Draft Main Document (appendix 3 to the report) and its key statements and recommendations be noted;
b) Consultation Report (appendix 1 to the report) be noted; and
c) the PNA be approved in principle for publication on 1 October 2025, with final approval delegated to the PNA working group.